Literature DB >> 1835485

TCR gamma delta cells: antigen-driven expansion of distinct subsets based on localization and antigen specificity.

P M Kluin1, C J Rust, M L Mearin, A S Peña, F Koning.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1835485     DOI: 10.1007/bf02919714

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


× No keyword cloud information.
  25 in total

Review 1.  T-cell responses to Mls and to bacterial proteins that mimic its behavior.

Authors:  C A Janeway; J Yagi; P J Conrad; M E Katz; B Jones; S Vroegop; S Buxser
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

2.  Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid.

Authors:  J Holoshitz; F Koning; J E Coligan; J De Bruyn; S Strober
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

3.  Specific recognition of staphylococcal enterotoxin A by human T cells bearing receptors with the V gamma 9 region.

Authors:  C J Rust; F Verreck; H Vietor; F Koning
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

4.  Intraepithelial T cells of the TcR gamma/delta+ CD8- and V delta 1/J delta 1+ phenotypes are increased in coeliac disease.

Authors:  T S Halstensen; H Scott; P Brandtzaeg
Journal:  Scand J Immunol       Date:  1989-12       Impact factor: 3.487

5.  Identification of a T3-associated gamma delta T cell receptor on Thy-1+ dendritic epidermal Cell lines.

Authors:  F Koning; G Stingl; W M Yokoyama; H Yamada; W L Maloy; E Tschachler; E M Shevach; J E Coligan
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

6.  Regulation of T-cell receptor gamma-chain RNA expression in murine Thy-1+ dendritic epidermal cells.

Authors:  W A Kuziel; A Takashima; M Bonyhadi; P R Bergstresser; J P Allison; R E Tigelaar; P W Tucker
Journal:  Nature       Date:  1987 Jul 16-22       Impact factor: 49.962

7.  A novel human V delta gene expressed predominantly in the Ti gamma A fraction of gamma/delta+ peripheral lymphocytes.

Authors:  F Triebel; F Faure; F Mami-Chouaib; S Jitsukawa; A Griscelli; C Genevée; S Roman-Roman; T Hercend
Journal:  Eur J Immunol       Date:  1988-12       Impact factor: 5.532

8.  T cell stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells.

Authors:  B Fleischer; H Schrezenmeier
Journal:  J Exp Med       Date:  1988-05-01       Impact factor: 14.307

9.  Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system.

Authors:  V Groh; S Porcelli; M Fabbi; L L Lanier; L J Picker; T Anderson; R A Warnke; A K Bhan; J L Strominger; M B Brenner
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  Two subsets of human T lymphocytes expressing gamma/delta antigen receptor are identifiable by monoclonal antibodies directed to two distinct molecular forms of the receptor.

Authors:  C Bottino; G Tambussi; S Ferrini; E Ciccone; P Varese; M C Mingari; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

View more
  3 in total

Review 1.  Human gammadelta-T cells in adoptive immunotherapy of malignant and infectious diseases.

Authors:  Richard D Lopez
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Intestinal antibody pattern of coeliac disease: association with gamma/delta T cell receptor expression by intraepithelial lymphocytes, and other indices of potential coeliac disease.

Authors:  E Arranz; J Bode; K Kingstone; A Ferguson
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

3.  Increase of circulating gamma/delta T lymphocytes in the peripheral blood of patients affected by active inflammatory bowel disease.

Authors:  R Giacomelli; I Parzanese; G Frieri; A Passacantando; F Pizzuto; T Pimpo; P Cipriani; A Viscido; R Caprilli; G Tonietti
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.